ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer.

D Ross Camidge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.